tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Macario-Barrel A et al. [Mouth ulcers in patients receiving tacrolimus]. 2001 Ann Dermatol Venereol pmid:11908135
Trotter JF et al. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. 2002 Liver Transpl. pmid:11910565
Taber DJ et al. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients. 2002 Liver Transpl. pmid:11910566
Trull A et al. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation. 2002 Liver Transpl. pmid:11910567
Gornet JM et al. Severe CPT-11-induced diarrhea in presence of FK-506 following liver transplantation for hepatocellular carcinoma. 2001 Nov-Dec Anticancer Res. pmid:11911319
Sugiura R [Functional analysis of calcineurin-mediated signalling pathway using fission yeast as a model system]. 2002 Nippon Yakurigaku Zasshi pmid:11915517
Segarra A et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. 2002 Nephrol. Dial. Transplant. pmid:11917061
Ikezumi Y et al. FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3. 2002 Kidney Int. pmid:11918741
Tamura S et al. Tacrolimus is a class II low-solubility high-permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. 2002 J Pharm Sci pmid:11920757
Oettinger-Barak O et al. Periodontal changes in liver cirrhosis and post-transplantation patients. II: radiographic findings:. 2002 J. Periodontol. pmid:11922262
Shimomura M et al. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. 2002 J. Surg. Res. pmid:11922737
Bueno OF et al. Calcineurin and hypertrophic heart disease: novel insights and remaining questions. 2002 Cardiovasc. Res. pmid:11922891
Fuchinoue S et al. Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal. 2002 Transplantation pmid:11923698
Lauzurica R et al. Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation. 2002 Transplantation pmid:11923710
Bolley R et al. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. 2002 Transplantation pmid:11923712
Panickar KS et al. Differential response of neural cells to trauma-induced free radical production in vitro. 2002 Neurochem. Res. pmid:11926270
Vitulo P et al. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation. 2002 J. Heart Lung Transplant. pmid:11927219
Wellington K and Jarvis B Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. 2002 Drugs pmid:11929333
Jacobsohn DA and Vogelsang GB Novel pharmacotherapeutic approaches to prevention and treatment of GVHD. 2002 Drugs pmid:11929336
Drosos AA Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy. 2002 Drugs pmid:11929337
Nishino K et al. Suppression of experimental immune-mediated blepharoconjunctivitis in Brown Norway rats by topical application of FK506. 2002 Graefes Arch. Clin. Exp. Ophthalmol. pmid:11931080
Armenti VT et al. National Transplantation Pregnancy Registry looks at outcomes with Neoral and Tacrolimus. 2000 Nephrol News Issues pmid:11933431
Schwarz NT et al. Protective effects of ex vivo graft radiation and tacrolimus on syngeneic transplanted rat small bowel motility. 2002 Surgery pmid:11935132
Shapiro AM et al. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. 2002 Diabetologia pmid:11935154
Goffin E et al. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. 2002 Transpl. Int. pmid:11935163
Nör JE et al. Ablation of microvessels in vivo upon dimerization of iCaspase-9. 2002 Gene Ther. pmid:11938459
Regentin R et al. Production of a novel FK520 analog in Streptomyces hygroscopicus: improving titer while minimizing impurities. 2002 J. Ind. Microbiol. Biotechnol. pmid:11938465
Udina E and Navarro X [Immunophilins: neuroprotective agents and promoters of neural regeneration]. 2002 Neurologia pmid:11940408
Reich K et al. Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitis. 2002 J. Allergy Clin. Immunol. pmid:11941319
Passos E et al. Ocular toxicity of intravitreal tacrolimus. 2002 Mar-Apr Ophthalmic Surg Lasers pmid:11942546
Chen GF et al. [Peripheral nerve regeneration under immunosuppression]. 2002 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:11944523
Li ZY et al. Dimerizer-induced proliferation of genetically modified hepatocytes. 2002 Mol. Ther. pmid:11945069
Turton-Weeks S et al. Pretransplant evaluation of a patient with acute intermittent porphyria. 2001 Prog Transplant pmid:11949465
Schwertfeger E et al. Contractile effects of tacrolimus in human and rat isolated renal arteries. 2001 J Auton Pharmacol pmid:11952876
Xie H et al. [Effect of FK506 eye-drop combined with keratoplasty on recurrent Mooren's ulcer]. 2002 Zhonghua Yan Ke Za Zhi pmid:11955293
Deppe CE et al. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. 2002 Endocrinology pmid:11956176
Robichaud GA et al. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. 2002 J. Biol. Chem. pmid:11956207
Trompeter R et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. 2002 Pediatr. Nephrol. pmid:11956848
Son IJ et al. Pharmacokinetic changes of intravenous tacrolimus in rats with uranyl nitrate-induced acute renal failure. 2000 Nov-Dec Res. Commun. Mol. Pathol. Pharmacol. pmid:11958289
Macleod MR and Butcher SP Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition. 2002 Neurosci. Lett. pmid:11958839
Norris CM et al. Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture. 2002 Neuroscience pmid:11958864
Latorre A et al. Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus. 2002 Transplant. Proc. pmid:11959186
Urbizu JM et al. Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience. 2002 Transplant. Proc. pmid:11959197
Pascual J and Ortuño J Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy. 2002 Transplant. Proc. pmid:11959198
Pascual J et al. One-center comparison between primary immunosuppression based on neoral cyclosporine and tacrolimus for renal transplantation. 2002 Transplant. Proc. pmid:11959200
Herrero JC et al. Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications. 2002 Transplant. Proc. pmid:11959201
Facundo C et al. Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation. 2002 Transplant. Proc. pmid:11959203
García-Meseguer C et al. Efficacy and safety of basiliximab in pediatric renal transplantation. 2002 Transplant. Proc. pmid:11959206
Machado PG et al. Use of reduced dose of OKT3 (2.5 mg) after renal transplantation. 2002 Transplant. Proc. pmid:11959207
Asensio M et al. Experience with tacrolimus as primary immunosuppressor in pediatric liver transplant. 2002 Transplant. Proc. pmid:11959208
Rafecas A et al. Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation. 2002 Transplant. Proc. pmid:11959209
Lladó L et al. Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation. 2002 Transplant. Proc. pmid:11959210
Molleví DG et al. Late xenograft rejection: comparison between liver and heart xenografts under low-dose tacrolimus. 2002 Transplant. Proc. pmid:11959212
Crespo-Leiro MG et al. Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy. 2002 Transplant. Proc. pmid:11959213
Sgrosso JL et al. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. 2002 Transplant. Proc. pmid:11959214
Alarcón-Zurita A et al. Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression. 2002 Transplant. Proc. pmid:11959216
Lauzurica R et al. Monotherapy with tacrolimus and corticosteroid withdrawal. 2002 Transplant. Proc. pmid:11959217
Sgrosso JL et al. Tacrolimus pharmacokinetics in heart transplant. 2002 Transplant. Proc. pmid:11959225
Roman A et al. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans. 2002 Transplant. Proc. pmid:11959227
Morell Ginestà M et al. Histology and immunopathology of heart and liver xenografts under low-dose tacrolimus. 2002 Transplant. Proc. pmid:11959305
Cofan F et al. Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus. 2002 Transplant. Proc. pmid:11959335
Pahl A et al. Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy. 2002 Br. J. Pharmacol. pmid:11959794
Bloom RD et al. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. 2002 J. Am. Soc. Nephrol. pmid:11961026
Vanderhoof JA and Young RJ Autoimmune enteropathy in a child: response to infliximab therapy. 2002 J. Pediatr. Gastroenterol. Nutr. pmid:11964960
Fujimura Y and Owen RL Tacrolimus (FK506) and cyclosporine reduce the uptake and transport of particles into rabbit Peyer's patches. 2002 Transplantation pmid:11965030
Ciancio G et al. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. 2002 Transplantation pmid:11965039
Itoh S et al. Inhibition of CN (protein phosphatase-2B) suppresses Ca2+-mediated acid secretion in rats. 2002 Aliment. Pharmacol. Ther. pmid:11966520
Sugawara Y et al. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. 2002 Clin Transplant pmid:11966779
Gonwa TA et al. Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody. 2002 Clin Transplant pmid:11966785
Ignatescu MC et al. Influence of mycophenolic acid and tacrolimus on homocysteine metabolism. 2002 Kidney Int. pmid:11967042
Ahmad SM et al. Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506). 2002 Cornea pmid:11973400
Abdelhadi M et al. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus. 2002 Transpl. Int. pmid:11976740
Müller WE et al. Histocompatibility reaction in tissue and cells of the marine sponge Suberites domuncula in vitro and in vivo: central role of the allograft inflammatory factor 1. 2002 Immunogenetics pmid:11976791
Ueno T et al. Evaluation of osteogenic/chondrogenic cellular proliferation and differentiation in the xenogeneic periosteal graft. 2002 Ann Plast Surg pmid:11981197
Chow KM et al. Good metabolic control using tacrolimus-based immunosuppressants in primary cadaveric renal transplantation in Chinese--a preliminary report. 2002 Clin Transplant pmid:11982613
Reimer J et al. Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. 2002 Clin Transplant pmid:11982615
Stratta RJ et al. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis. 2002 Clin Transplant pmid:11982617
Al-Daraji WI et al. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. 2002 J. Invest. Dermatol. pmid:11982754
Danovitch GM How should the immunosuppressive regimen be managed in patients with established chronic allograft failure? 2002 Kidney Int. Suppl. pmid:11982816
Strauss G et al. Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. 2002 Clin. Exp. Immunol. pmid:11985515
Krishnadasan B et al. Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus. 2002 J. Thorac. Cardiovasc. Surg. pmid:11986604
Reinhard T et al. [Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study]. 2002 Klin Monbl Augenheilkd pmid:11987039
Ortiz de Frutos FJ [New horizons in the treatment of atopic dermatitis]. Allergol Immunopathol (Madr) pmid:11988144
Chen QS et al. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. 2002 Neurobiol Learn Mem pmid:11991763
Minematsu T et al. Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect. 2001 J Pharmacokinet Pharmacodyn pmid:11999291
Reding R et al. Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipients. 2002 Pediatr Transplant pmid:12000467
Wang SJ Interaction between FK 506 and isoproterenol in the modulation of glutamate release from cerebrocortical nerve terminals. 2002 Neuroreport pmid:12004204
Granot E et al. Markers of oxidative stress in cyclosporine-treated and tacrolimus-treated children after liver transplantation. 2002 Liver Transpl. pmid:12004347
Deters M et al. Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS). 2002 Clin. Chem. Lab. Med. pmid:12005219
Grand AG et al. Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. 2002 J. Neurosurg. pmid:12005401
Henthorn DC et al. A GAL4-based yeast three-hybrid system for the identification of small molecule-target protein interactions. 2002 Biochem. Pharmacol. pmid:12007565
Skuk D et al. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. 2002 Exp. Neurol. pmid:12009764
Sulaiman OA et al. FK506 increases peripheral nerve regeneration after chronic axotomy but not after chronic schwann cell denervation. 2002 Exp. Neurol. pmid:12009765
Logan AJ et al. Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study. 2002 Clin Transplant pmid:12010137
Abouljoud MS et al. Neoral rescue therapy in transplant patients with intolerance to tacrolimus. 2002 Clin Transplant pmid:12010138
Cantin B et al. Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection. 2002 Clin Transplant pmid:12010143
Muscella A et al. Muscarinic acetylcholine receptor activation induces Ca2+ mobilization and Na+/K+-ATPase activity inhibition in eel enterocytes. 2002 J. Endocrinol. pmid:12010640
Welm BE et al. Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. 2002 J. Cell Biol. pmid:12011115
Ahn SC et al. A tactic for screening inhibitors of interleukin-2 production. 2002 Anal. Biochem. pmid:12018952
Heering P et al. Hemolytic uremic syndrome after renal transplantation: immunosuppressive therapy with rapamycin. 2002 Nephron pmid:12021541